Industry Pipeline - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Pipeline
Interphex Showcase 2010.

Pharmaceutical Technology
Volume 34, Issue 4, pp. 128-135



Noncontact process analyzer
The XDS Process Analytics Direct Light is a noncontact process analyzer for real-time analysis in the pharmaceutical industry. The instrument performs nondestructive in-line near-infrared analysis of moving products. Noncontact reflectance measurements can provide in-depth chemical analysis for homogeneous or nonhomogeneous solid products directly in the product line. FOSS NIRSystems, Laurel, MD http://www.foss-nirsystems.com/ tel. 301.680.9600



Stackable stability chambers
Caron's 10-ft3 stability chambers were designed in accordance with ICH Guideline Q1A. The units are suited for applications such as new drug compound testing; product shelf life testing; stability and packaging testing; and temperature and relative humidity (RH) studies. The stackable configuration enables independent temperature and RH settings. Caron Products and Services, Marietta, OH http://www.caronproducts.com/ tel. 740.373.6809



Laboratory blenders
MaxiBlend and MiniBlend laboratory blenders are available in sizes from 0.5 to 16 qt. The units are made of 316-L stainless steel and supplied with V-shells, bins, or double cones. The units feature a tabletop design and include programmable logic controls and safety-interlocked guards. GlobePharma, New Brunswick, NJ http://www.globepharma.com/ tel. 732.819.0381



Total-organic-carbon analyzer
The Anatel TOC600 on-line total-organic-carbon analyzer is designed for pharmaceutical water measurement. Its patented stop-flow oxidation technology provides complete oxidation of an aliquot of water and fully complies with USP Chapter <643> and EP 2.2.44. The Anatel TOC600 unit's wide dynamic range allows for monitoring an array of water-system applications. Hach Ultra Analytics, Grants Pass, OR http://www.hachultra.com/ tel. 541.472.6500

INFORMATION TECHNOLOGY



Quality and compliance management
EtQ for Pharmaceuticals is an integrated quality- and compliance-management system that is preconfigured to address the pharmaceutical industry's needs. EtQ's modular approach provides flexibility and automation. Key modules include corrective and preventive actions, document control, risk management, audits, training, and reporting. EtQ, Farmingdale, NY http://www.etq.com/ tel. 800.354.4476


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
14%
To select process for new products only
23%
To select processes for both new and legacy products
20%
Do not use QbD
25%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here